Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
ZOZO, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 13%, Oct-Dec Ordinary Profit Increases by 27%
3092 ZOZO,Inc. 【J-GAAP】
Earnings ReportZOZO,Inc. <3092> [TSE Prime] announced its financial results after the market closed on January 31st (15:30). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending March 2025 (April to December) increased 12.9% from the same period last year, reaching 51.8 billion yen. The progress rate toward the full-year plan of 64.2 billion yen was 80.7%, also surpassing the five-year average of 76.0%.
Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the January to March period (4Q) is expected to decrease 10.7% from the same period last year to 12.3 billion yen.
In the most recent three-month period, from October to December (3Q), the consolidated ordinary profit grew 26.9% from the same period last year, reaching 21.3 billion yen. The operating profit margin rose from 29.2% in the same period last year to 34.2%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Apr - Dec, 2022 | 136,467 | 44,635 | 44,872 | 31,213 | 34.7 | 79.1 | Jan 31, 2023 | J-GAAP |
Apr - Dec, 2023 | 147,568 | 45,698 | 45,906 | 32,470 | 36.1 | 76.8 | Jan 31, 2024 | J-GAAP |
Apr - Dec, 2024 | 161,076 | 51,761 | 51,829 | 35,943 | 40.4 | 80.7 | Jan 31, 2025 | J-GAAP |
YoY | +9.2% | +13.3% | +12.9% | +10.7% | +11.8% |
Current Period Guidance
Second Half Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Mar, 2023 | 106,799 | 31,148 | 30,660 | 24,027 | 26.8 | 18.34 | Apr 30, 2024 | J-GAAP |
Oct - Mar, 2024 Guidance | 115,599 | 33,725 | 33,687 | 24,070 | 27.0 | 18 | Oct 31, 2024 | J-GAAP |
YoY | +8.2% | +8.3% | +9.9% | +0.2% | +0.9% |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2023 | 183,423 | 56,421 | 56,716 | 39,526 | 43.9 | 21.67 | Apr 27, 2023 | J-GAAP |
Mar, 2024 | 197,016 | 60,079 | 59,764 | 44,341 | 49.4 | 34.67 | Apr 30, 2024 | J-GAAP |
Mar, 2025 Guidance | 214,400 | 64,200 | 64,200 | 45,200 | 50.7 | 35.67 | Apr 30, 2024 | J-GAAP |
YoY | +8.8% | +6.9% | +7.4% | +1.9% | +2.7% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Dec, 2023 | 57,351 | 16,767 | 16,802 | 12,156 | 13.5 | 29.2 | Jan 31, 2024 | J-GAAP |
Jan - Mar, 2024 | 49,448 | 14,381 | 13,858 | 11,871 | 13.2 | 29.1 | Apr 30, 2024 | J-GAAP |
Apr - Jun, 2024 | 50,387 | 15,895 | 15,892 | 11,109 | 12.5 | 31.5 | Jul 31, 2024 | J-GAAP |
Jul - Sep, 2024 | 48,414 | 14,580 | 14,621 | 10,021 | 11.3 | 30.1 | Oct 31, 2024 | J-GAAP |
Oct - Dec, 2024 | 62,275 | 21,286 | 21,316 | 14,813 | 16.6 | 34.2 | Jan 31, 2025 | J-GAAP |
YoY | +8.6% | +27.0% | +26.9% | +21.9% | +23.0% |
Related Articles
MEIDENSHA, The Current Fiscal Year Ordinary Profit Revised Upward by 19%, Raises Record High Profit Forecast
Sumitomo Pharma, The Current Fiscal Year Net Income Turns to Profit, Exceeds Expectations
TDSE, The Current Fiscal Year Ordinary Profit Revised Upward by 35%
NSK, Apr-Dec (Cumulative 3Q) Net Income Decreases by 17%, Oct-Dec Net Income Decreases by 52%
ZEON, The Current Fiscal Year Ordinary Profit Revised Upward to an Unexpected 11% Increase
NIPPON CHUTETSUKAN, The Current Fiscal Year Ordinary Profit Revised Downward by 17%
SMN, Oct-Dec (3Q) Ordinary Profit Decreases by 48%
G-7 HOLDINGS, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 1%
MAX, The Current Fiscal Year Ordinary Profit Revised Upward by 3%, Raises Record High Profit Forecast, Dividend Revised Upward by 4 yen
TOWNNEWS-SHA, Oct-Dec (2Q) Ordinary Profit Increases by 34%